Kidney Tubular Functions in Type 1 Diabetes
1 型糖尿病的肾小管功能
基本信息
- 批准号:10449358
- 负责人:
- 金额:$ 64.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidosisAlbuminsAlbuminuriaArginineAtrophicBasement membraneBiological AssayBiopsyBlood capillariesCardiovascular DiseasesCathepsinsCellsCessation of lifeCharacteristicsChronic Kidney FailureCitrullineClinicalClinical TrialsComplicationDataDevelopmentDiabetes MellitusDiabetic NephropathyDiagnosisDiseaseDisease ProgressionDistalEnd stage renal failureEpidermal Growth FactorEpithelial CellsErythropoiesisEvolutionExcretory functionExposure toFibrosisFutureGlomerular Filtration RateGlucoseGlycosylated hemoglobin AGoalsGoldImpairmentInflammatoryInjuryInjury to KidneyInsulin-Dependent Diabetes MellitusInterventionIohexolKidneyKidney DiseasesKidney FailureLaboratoriesLesionMeasurementMeasuresMetabolicMetabolismMethodsMineralsMonitorNatural HistoryNon-Insulin-Dependent Diabetes MellitusParentsPathogenesisPathologicPathologyPathway interactionsPatternPersonsPlasmaPreventionProteomicsRenal functionRenal tubule structureRenin-Angiotensin SystemRiskRisk FactorsSamplingSclerosisSeveritiesSodiumStressStructureTestingThickTimeTranslatingTubular formationUrineWorkbasebiomarker developmentcohortdisorder subtypeglomerular basement membraneglomerular filtrationglomerular functionglucose monitorhigh riskhuman diseaseimprovedinhibitorinterstitialkidney biopsylysosomal proteinsmodifiable risknew therapeutic targetnovelpodocyteprecision medicineprematurepreventrat KIM-1 proteinrenal damageresearch clinical testingsolutesymporterurinary
项目摘要
ABSTRACT
Chronic kidney disease is a common and serious complication of type 1 diabetes (T1D). Historically, diabetes
has been viewed as a primary glomerular kidney disorder based on classic pathological features. However,
diabetes also promotes injury to kidney tubular epithelial cells and their microenvironment through increased
work of glucose reabsorption and direct stimulation of pro-inflammatory and pro-fibrotic pathways. Sodium
glucose co-transporter-2 inhibitors, which block glucose entry into proximal tubular cells, are the most
promising new treatment for slowing the progression of kidney disease in type 2 diabetes.
Compelling mechanisms of kidney tubular injury in diabetes have been incompletely translated into human
disease, impeding new strategies for monitoring and treatment. The goal of this proposal is to advance
understanding of the evolution, determinants, and clinical consequences of kidney tubular functions in persons
with type I diabetes (T1D). We will add novel measurements of tubular functions and damage to two landmark
clinical trials of T1D spanning the course of kidney disease. Through these measurements, we will for the first
time characterize the natural history of tubular functions over time in T1D, identify potential risk factors for the
loss of tubular functions, and test whether measures of tubular functions and damage are associated with
metabolic complications, changes in key pathologic features, and a decline in glomerular kidney functions. The
construction of a detailed natural history of kidney tubular functions in T1D will lay needed groundwork for the
future development of new interventions to improve prevention, monitoring, and treatment.
抽象的
慢性肾脏病是 1 型糖尿病 (T1D) 的常见且严重的并发症。历史上,糖尿病
根据典型的病理特征,被视为原发性肾小球肾病。然而,
糖尿病还通过增加肾小管上皮细胞及其微环境的损伤来促进肾小管上皮细胞及其微环境的损伤。
葡萄糖重吸收的作用以及直接刺激促炎和促纤维化途径。钠
葡萄糖协同转运蛋白 2 抑制剂可阻止葡萄糖进入近端肾小管细胞,是最有效的抑制剂。
有望减缓 2 型糖尿病肾病进展的新疗法。
糖尿病肾小管损伤的令人信服的机制尚未完全转化为人类
疾病,阻碍新的监测和治疗策略。该提案的目标是推进
了解人体肾小管功能的演变、决定因素和临床后果
患有 I 型糖尿病 (T1D)。我们将为两个地标添加管状功能和损伤的新颖测量
T1D 跨越肾脏疾病病程的临床试验。通过这些测量,我们将首先
时间表征 T1D 中肾小管功能随时间变化的自然历史,识别潜在的危险因素
肾小管功能丧失,并测试肾小管功能和损伤的测量是否与
代谢并发症、关键病理特征的变化以及肾小球肾功能下降。这
构建 T1D 肾小管功能的详细自然史将为以下研究奠定必要的基础:
未来制定新的干预措施以改善预防、监测和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRYAN R KESTENBAUM其他文献
BRYAN R KESTENBAUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRYAN R KESTENBAUM', 18)}}的其他基金
Role of Kidney Proximal Tubular Secretion in Critical Illness
肾近端肾小管分泌在危重疾病中的作用
- 批准号:
10398127 - 财政年份:2020
- 资助金额:
$ 64.09万 - 项目类别:
Role of Kidney Proximal Tubular Secretion in Critical Illness
肾近端肾小管分泌在危重疾病中的作用
- 批准号:
10217335 - 财政年份:2020
- 资助金额:
$ 64.09万 - 项目类别:
Role of Kidney Proximal Tubular Secretion in Critical Illness
肾近端肾小管分泌在危重疾病中的作用
- 批准号:
9916616 - 财政年份:2020
- 资助金额:
$ 64.09万 - 项目类别:
Role of Kidney Proximal Tubular Secretion in Critical Illness
肾近端肾小管分泌在危重疾病中的作用
- 批准号:
10620671 - 财政年份:2020
- 资助金额:
$ 64.09万 - 项目类别:
Midcareer Investigator Award: Metabolic Complications of Chronic Kidney Disease
职业生涯中期研究员奖:慢性肾脏病的代谢并发症
- 批准号:
9901518 - 财政年份:2016
- 资助金额:
$ 64.09万 - 项目类别:
Mineral metabolism disturbances and arteriovenous fistula maturation
矿物质代谢紊乱和动静脉瘘成熟
- 批准号:
8549212 - 财政年份:2012
- 资助金额:
$ 64.09万 - 项目类别:
Mineral metabolism disturbances and arteriovenous fistula maturation
矿物质代谢紊乱和动静脉瘘成熟
- 批准号:
8436693 - 财政年份:2012
- 资助金额:
$ 64.09万 - 项目类别:
相似海外基金
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10685312 - 财政年份:2021
- 资助金额:
$ 64.09万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10490872 - 财政年份:2021
- 资助金额:
$ 64.09万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10345963 - 财政年份:2021
- 资助金额:
$ 64.09万 - 项目类别:
Development of Highly Functionalized Serum Albumins as Boron Delivery Carries to Tumor for Neutron Capture Therapy
开发高功能化血清白蛋白作为硼输送至肿瘤以进行中子捕获治疗
- 批准号:
17H02202 - 财政年份:2017
- 资助金额:
$ 64.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on Asymmetric Nitroaldol Reaction using mutant albumins
突变体白蛋白不对称硝醛醇反应的研究
- 批准号:
16K05706 - 财政年份:2016
- 资助金额:
$ 64.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SPIN LABELING STUDIES OF NORMAL RECOMBINANT & MUTANT HUMAN SERUM ALBUMINS
正常重组的旋转标记研究
- 批准号:
6118869 - 财政年份:1999
- 资助金额:
$ 64.09万 - 项目类别:
COPPER BINDING OF COMMERCIAL, NORMAL RECOMBINANT, & MUTANT HUMAN SERUM ALBUMINS
商业、正常重组的铜结合,
- 批准号:
6118864 - 财政年份:1999
- 资助金额:
$ 64.09万 - 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia in Fowl
家禽双清蛋白血症血清白蛋白的结构与代谢特征
- 批准号:
67B6472 - 财政年份:1967
- 资助金额:
$ 64.09万 - 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia
双清蛋白血症血清白蛋白的结构和代谢特征
- 批准号:
65B3344 - 财政年份:1965
- 资助金额:
$ 64.09万 - 项目类别: